- What it is: A blend of four separate research peptides, BPC-157, TB-500, GHK-Cu and KPV, combined in one vial.
- Researchers have studied the components for: soft-tissue and tendon repair (BPC-157), wound closure and cell migration (TB-500), matrix remodeling in skin cells (GHK-Cu), and inflammatory signaling in gut and immune cells (KPV).
- Evidence level: Each compound has its own preclinical literature, mostly animal and lab-dish work, with a small amount of human data on Thymosin Beta-4. No published study has tested the four compounds together.
- The short version: This is four separately studied compounds sitting in one vial. Each has its own research history that has nothing to do with the other three. What has not been studied is the combination, in any species, so anything said about how they behave as a group is inference rather than evidence.
KLOW supplies BPC-157, TB-500, GHK-Cu and KPV pre-blended in a single lyophilized vial, 80mg total. It ships as one vial, not as a multi-vial kit, and as powder only.
The four are grouped because researchers often study them in overlapping tissue-repair contexts, not because any trial has evaluated them as a group. That distinction is stated on the research page rather than glossed over.
For research use only. Not for human consumption. Nothing on this page is medical advice, a health claim, or a recommendation to use.


